Nimodipine after aneurysmal subarachnoid hemorrhage: shortened treatment in an unselected patient cohort

A shortened nimodipine treatment period in patients without DCI after aSAH could be feasible. This may reduce sleep deprivation of patients and more effective utilization of neurointensive care resources. A large, randomized study is required to answer the question whether a shorter treatment with nimodipine is adequate to give full benefit of the medication in patients without signs and symptoms of DCI.